Physician financial relationships in the new regulatory environment.
In recent months, physicians have been under scrutiny by the federal government with respect to their financial relationships with both drug manufacturers and home care companies. This heightened scrutiny can be attributed, in part, to the attention that has been placed on health care fraud and abuse in this country as a major cause of rising health care costs. Federal investigators currently are examining physician financial relationships in light of the Medicare/Medicaid antikickback statute to determine whether certain payments made to physicians are intended as inducements to refer patients or to prescribe certain products. "Health Law" is a regular feature of Physician Executive contributed by Epstein Becker & Green. Mark Lutes of the law firm's Washington, D.C., offices serves as column editor.
R D
RD
Roberts
D004345:Drug Industry; D005607:Fraud / Q000331:legislation & jurisprudence*; D018574:Home Care Agencies; D016365:Liability, Legal; D018584:Physician Self-Referral / Q000331:legislation & jurisprudence*; D014481:United States